Zusammenfassung
Papillome sind Tumoren, welche von der Schleimhaut ihren Ursprung nehmen. Diese können im Bereich der Nase/Nasennebenhöhlen, der Mundhöhle, des Oropharynx, des Larynx, der Trachea und der Haut vorkommen. Meist handelt es sich um Zufallsbefunde, da Papillome selten Beschwerden machen. Eine Ausnahme bildet die Larynxpapillomatose, welche mit Stridor, Dyspnoe und Heiserkeit einhergeht. Ursächlich wird eine virale Genese diskutiert – hier v. a. eine Infektion mit humanen Papillomaviren (HPV). Eine mechanische Genese bei Affektion von Nase und Mundhöhle bzw. Oropharynx kann nicht ausgeschlossen werden. Allen Papillomen, unabhängig von ihrer Lokalisation, sind die Rezidivfreudigkeit sowie die Potenz zur malignen Entartung gemeinsam. Therapie der Wahl ist die komplette Exzision. Bei der Larynxpapillomatose wird vielfach die Laservaporisation bzw. -exzision mit dem CO2-Laser bevorzugt. Da die chirurgische Intervention aufgrund der Rezidive oft wiederholt durchgeführt werden muss, werden v. a. bei der Larynxpapillomatose adjuvante Therapien mit der Zielsetzung angewendet, die Rezidivrate zu senken und die Intervalldauer zu verlängern.
Abstract
Papillomas are rare tumors that originate from the mucosa. They may appear in the nose, paranasal sinuses, oral cavity, larynx, trachea, or the skin. Papillomas are mainly asymptomatic and are therefore mostly diagnosed coincidentally. In contrast, laryngeal papillomatosis may cause stridor, dyspnoea, and hoarseness. A viral cause of the disease seems likely, especially human papilloma virus. Mechanical irritation is also a possible reason when the nose, oral cavity, or oropharynx is affected. All papillomas, independent of their origin, may recur, and have the possibility of malignant degeneration in common. The therapy of choice is complete surgical excision. Regarding laryngeal papillomatosis, laser vaporisation or excision using the CO2 laser is recommended. Because retreatments using conventional modalities are frequently necessary, especially in the case of laryngeal papillomatosis, adjuvant therapies are applied with the aim of reducing the recurrence rate and prolonging the interval between treatments.
Literatur
Aaltonen LM, Rikhanen H, Vaheri A (2002) Human papillomavirus in larynx. Laryngoscope 112: 700–707
Abramson AL, Waner M, Brandsma J (1988) The clinical treatment of laryngeal papillomas with hematoporphyrin therapy. Arch Otolaryngol Head Neck Surg 114: 795–800
Abramson AL, Shikowitz MJ, Mullooly VM et al. (1992) Clinical effects of photodynamic therapy on recurrent laryngeal papillomas. Arch Otolaryngol Head Neck Surg 118: 25–29
Abramson AL, Shikowitz MJ, Mullooly VM et al. (1994) Variable light-dose effect on photodynamic therapy for laryngeal papillomas. Arch Otolaryngol Head Neck Surg 120: 852–855
Abramson AL, Nouri M, Mullooly V et al. (2004) Latent human papillomavirus infection is comparable in the larynx and trachea. J Med Virol 72: 473–477
Allen A, Siegfried E (2000) What’s new in human papillomavirus infection? Cur Opin Ped 12: 365–369
Armstrong LR, Derkay CS, Reeves WC (1999) Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP task force. Arch Otolaryngol Head Neck Surg 125: 743–748
Beadle JR, Hartline C, Aldern KA et al. (2002) Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro. Antimicrob Agents Chemother 46: 2381–2386
Bedard J, May S, Lis M et al. (1999) Comparative study of the anti-human cytomegalovirus activities and toxicities of a tetrahydrofuran phosphonate analogue of guanosine and cidofovir. Antimicrob Agents Chemother 43: 557–567
Bergler W, Honig M, Gotte K et al. (1997) Treatment of recurrent respiratory papillomatosis with argon plasma coagulation. J Laryngol Otol 111: 381–384
Bonagura VR, Vambutas A, DeVoti JA et al. (2004) HLA alleles, IFN-gamma responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis. Hum Immunol 65: 773–782
Bosch FX, Manos MM, Munoz N et al. (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 87: 796–802
Bower CM, Waner M, Flock S, Schaeffer R (1998) Flash pump dye laser treatment of laryngeal papillomas. Ann Otol Rhinol Laryngol 107: 1001–1005
Bujia J, Feyh J, Kastenbauer E (1993) Terapia fotodinamica con derivados hematoporfirinicos en la papillomatosis laringeal infantil recidivante. Primeros resultados. An Otorrinolaringol Ibero Am 20: 251–259
Capper JW, Bailey CM, Michaels L (1983) Squamous papillomas of the larynx in adults. A review of 63 cases. Clin Otolaryngol Allied Sci 8(2): 109–119
Cohen JT, Koufman JA, Postma GN (2003) Pulsed-dye laser in the treatment of recurrent respiratory papillomatosis of the larynx. Ear Nose Throat J 82: 558
Dedo H, Yu K (2001) CO2 laser treatment in 244 patients with respiratory papillomas. Laryngoscope 111: 1639–1644
Derkay CS (1995) Task force on recurrent respiratory papillomas. A preliminary report. Arch Otolaryngol Head Neck Surg 121: 1386–1391
Derkay CS (2001) Recurrent respiratory papillomatosis. Laryngoscope 111: 57–69
Derkay CS, Smith RJ, McClay J et al. (2005) HspE7 treatment of pediatric recurrent respiratory papillomatosis: final results of an open-label trial. Ann Otol Rhinol Laryngol 114: 730–737
Feyh J, Kastenbauer E (1992) Die Behandlung der Larynxpapillomatose mit Hilfe der photodynamischen Lasertherapie. Laryngorhinootologie 71: 190–192
Feyh J, Gutmann R, Leunig A (1993) Die photodynamische Lasertherapie im Bereich der Hals-, Nasen-, Ohrenheilkunde. Laryngorhinootologie 72: 273–278
Gabbot M, Cossart YE, Kan A et al. (1997) Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis. J Clin Microbiol 35: 3098–3103
Gelder CM, Williams OM, Hart KW et al. (2003) HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis. J Virol 77: 1927–1939
Gerein V, Rastorguev E, Gerein J et al. (2005) Incidence, age at onset and potential reasons of malignant transformation in recurrent respiratory papillomatosis patients: 20 years experience. Otolaryngol Head Neck Surg 132: 392–394
Harcourt JP, Worley G, Leighton SE (1999) Cimetidine treatment for recurrent respiratory papillomatosis. Int J Ped Otolaryngol 51: 109–113
Hartnick CJ, Boseley ME, Franco RA et al. (2007) Efficacy of treating children with anterior commissure and true vocal fold respiratory papilloma with the 585-nm pulsed-dye laser. Arch Otolaryngol Head Neck Surg 133: 127–130
Healy GB, Gelber RD, Trowbridge AL et al. (1988) Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial. N Engl J Med 319: 401–407
Ho GY, Bierman R, Beardsley L et al. (1998) Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338: 423–428
Holland B, Koufman J, Postma G, McGuirt W (2002) Laryngopharyngeal reflux and laryngeal web formation in patients with pediatric recurrent respiratory papillomas. Laryngoscope 112: 1926–1929
Janda P, Leunig A, Soak R et al. (2004) Preliminary report of end laryngeal and endotracheal laser surgery of juvenile-onset recurrent respiratory papillomatosis by Nd:YAG laser and a new fiber guidance instrument. Otolaryngol Head Neck Surg 131: 44–49
Kashima HK, Shah F, Lyles A et al. (1992) A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope 102: 9–13
Kavuru MS, Mehta AC, Eliachar I (1990) Effect of photodynamic therapy and external beam radiation therapy on juvenile laryngotracheobronchial papillomatosis. Am Rev Respir Dis 141: 509–510
Kosko JR, Derkay CS (1996) Role of cesarean section in prevention of recurrent respiratory papillomatosis--is there one? Int J Pediatr Otorhinolaryngol 35: 31–38
Kramer SS, Wehunt WD, Stocker IT (1985) Pulmonary manifestations of juvenile laryngotracheal papillomatosis. A J Roentgenol 144: 687–694
Lee JH, Smith RJ (2005) Recurrent respiratory papillomatosis: pathogenesis to treatment. Curr Opin Otolaryngol Head Neck Surg 13: 354–359
Lindeberg H, Oster S, Oxlund I, Elbrønd O (1986) Laryngeal papillomas: classification and course. Clin Otolaryngol Allied Sci 11(6): 423–429
Leunig A, Betz CS, Mehlmann M et al. (2000) A pilot serie demonstrating fluorescence staining of laryngeal papilloma using 5-aminolevulinic acid. Laryngoscope 110: 1783–1785
Leunig A, Betz CS (2003) Fluoreszenzdiagnostik in der HNO-Heilkunde. IN: Szeimies R-M, Jocham D, Landthaler M. Klinische Fluoreszenzdiagnostik und Photodynamische Therapie. Blackwell, Berlin S 106–119
McGlennen RC, Adams GL, Lewis CM et al. (1993) Pilot trial of ribavirin for the treatment of laryngeal papillomatosis. Head Neck 15: 504–512 (discussion 512–513)
McKenna M, Brodsky L (2005) Extraoesophageal acid reflux and recurrent respiratory papilloma in children. Int J Ped Otolaryngol 69: 597–605
McMillan K, Shapshay SM, McGilligan JA et al. (1998) A 585-nanometer pulsed dye laser treatment of laryngeal papillomas: preliminary report. Laryngoscope 108: 968–972
Mullooly VM, Abramson AL, Shikowitz MJ (1990) Dihematoporphyrin ether-induced photosensitivity in laryngeal papilloma patients. Lasers Surg Med 10: 349–356
Naiman AN, Ceruse P, Coulombeau B, Froehlich P (2003) Intralesional cidofovir and surgical excision for laryngeal papillomatosis. Laryngoscope 113: 2174–2181
Neumann K, Pudszuhn A, Welzel C et al. (2003) Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results. Laryngorhinootologie 82: 700–706
Pasquale K, Wiatrak B, Woolley A, Lewis L (2003) Microdebrider versus CO2 laser removal of recurrent respiratory papillomas: a prospective analysis. Laryngoscope 113: 139–143
Patel N, Rowe M, Tunkel D (2003) Treatment of recurrent respiratory papillomatosis in children with the microdebrider. Ann Otol Rhinol Laryngol 112: 7–10
Pou AM, Rimell FL, Jordan JA et al. (1995) Adult respiratory papillomatosis: human papillomavirus type and viral coinfections as predictors of prognosis. Ann Otol Rhinol Laryngol 104: 758–762
Pransky SM, Albright JT, Magit AE (2003) Long-term follow-up of pediatric recurrent respiratory papillomatosis managed with intralesional cidofovir. Laryngoscope 113: 1583–1587
Pudzuhn A, Welzel C, Bloching M, Neumann K (2007) Intralesional cidofovir application in recurrent laryngeal papillomatosis. Eur Arch Otorhinolaryngol 264: 63–70
Puranen M, Yliskoski M, Saarikoski S et al. (1996) Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood. Am J Obstet Gynecol 174: 694–699
Rihkanen H, Aaltonen LM, Syrjanen SM (1993) Human papillomavirus in laryngeal papillomas and in adjacent normal epithelium. Clin Otolaryngol Allied Sci 18: 470–474
Rosen CA, Bryson PC (2004) Indole-3-carbinol for recurrent respiratory papillomatosis: long-term results. J Voice 18: 248–253
Schraff S, Derkay CS, Burke B, Lawson L (2004) American society of pediatric otolaryngology members‘ experience with recurrent respiratory papillomatosis and the use of adjuvant therapy. Arch Otolaryngol Head Neck Surg 130: 1039–1042
Shehab N, Sweet BV, Hogikyan ND (2005) Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature. Pharmacotherapy 25: 977–989
Shikowitz MJ, Abramson AL, Freeman K et al. (1998) Efficacy of DHE photodynamic therapy for respiratory papillomatosis: immediate and long-term results. Laryngoscope 108: 962–967
Shikowitz MJ, Abramson AL, Steinberg BM et al. (2005) Clinical trial of photodynamic therapy with meso-tetra (hydroxyphenyl) chlorin for respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 131: 99–105
Summersgill KF, Smith EM, Levy BT et al. (2001) Human papillomavirus in the oral cavities of children and adolescents. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91: 62–69
Tenti P, Zappatore R, Migliora P et al. (1999) Perinatal transmission of human papillomavirus from gravidas with latent infections. Obstet Gynecol 93: 475–479
Tseng CJ, Liang CC, Soong YK, Pao CC (1998) Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery. Obstet Gyneco 9: 92–96
Ullman UV (1923) On the aetiology of the laryngeal papillomata. Acta Otolaryngol 5: 317–334
Uloza V (2000) The course of laryngeal papillomatosis treated by end laryngeal microsurgery. Eur Arch Otorhinolaryngol 257: 498–501
Ulualp SO, Ryan MW, Wright ST (2007) Microdebrider removal of tracheal papilloma via tracheostomy in the child with an obliterated larynx. J Laryngol Otol 10: 1–3
Vambutas A, DeVoti J, Pinn W et al. (2001) Interaction of human papillomavirus type 11 E7 protein with TAP-1 results in the reduction of ATP-dependent peptide transport. Clin Immunol 101: 94–99
Van Valckenborgh I, Wellens W, de Boeck K et al. (2001) Systemic cidofovir in papillomatosis. Clin Inf Dis 32: 62–64
Weiss MD, Kashima HK (1983) Tracheal involvement in laryngeal papillomatosis. Laryngoscope 93: 45–48
Wemer RD, Lee JH, Hoffman HT et al. (2005) Case of progressive dysplasia concomitant with intralesional cidofovir administration for recurrent respiratory papilomatosis. Ann Otol Rhinol Laryngol 114: 836–839
Zeitels SM, Franco RA, Dailey SH et al. (2004) Office-based treatment of glottal dysplasia and papillomatosis with the 585-nm pulsed dye laser and local anesthesia. Ann Otol Rhinol Laryngol 113: 265–276
Interessenkonflikt
Die korrespondierende Autorin gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Andratschke, M., Betz, C. & Leunig , A. Larynxpapillomatose. HNO 56, 1190–1196 (2008). https://doi.org/10.1007/s00106-008-1711-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00106-008-1711-4